Jonathan Eliot Sears MD
Retinal Disease
Staff, Cole Eye Institute, Cleveland Clinic
Join to View Full Profile
Cleveland Clinic, Cole Eye Institute9500 Euclid AvenueCleveland, OH 44195
Phone+1 216-444-8157
Fax+1 216-445-2226
Dr. Sears is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Sears is an ophthalmologist based in Cleveland, OH, specializing in retinal diseases. He completed his medical education at Yale School of Medicine, followed by an internship and residency at Yale-New Haven Medical Center, and a fellowship in Surgical Retina and Vitreous at Emory University School of Medicine. Dr. Sears treats both pediatric and adult retina patients. He is the principle investigator in a R01 funded bench science investing HIF stabilization to eradicate retinopathy of prematurity.
Education & Training
Emory University School of MedicineFellowship, Surgical Retina and Vitreous, 1996 - 1998
Yale-New Haven Medical CenterResidency, Ophthalmology, 1993 - 1996- Yale-New Haven Medical CenterInternship, Internal Medicine, 1992 - 1993
Yale School of MedicineClass of 1992
Certifications & Licensure
OH State Medical License 1998 - 2026
GA State Medical License 1996 - 1999
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema.Gabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan, Sunil K Srivastava, Peter K Kaiser
Journal of Vitreoretinal Diseases. 2025-10-04 - 3 citationsInitial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular Degeneration.Suraj Bala, Gabriel C S Barbosa, Nitesh Mohan, Sunil K Srivastava, Peter K Kaiser
Ophthalmology. Retina. 2025-08-01 - Characterization of Hepatotropic Small Molecule Inhibitors of Hypoxia Inducible Factor Prolyl Hydroxylase in the Prevention of Oxygen-Induced Retinopathy.Christie Campla, George Hoppe, Minzhong Yu, Juliana Woda, Neal S Peachey
Journal of Medicinal Chemistry. 2025-06-26
Press Mentions
The HIF Stabilizer Roxadustat Doesn’t Lead to Pathological Retinal AngiogenesisApril 29th, 2019
Grant Support
- Multi-organ protection against hyperoxia of the preterm infantNational Eye Institute2025–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
